Replies to post #130325 on Biotech Values

[DewDiligence]

DEB025 doesn’t need to show great efficacy as monotherapy. Its function in HCV cocktails will be to add modest incremental efficacy without generating any mutant HCV strains whatsoever (because it targets a host protein).